B. Klinger

2.0k total citations
43 papers, 1.5k citations indexed

About

B. Klinger is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, B. Klinger has authored 43 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in B. Klinger's work include Growth Hormone and Insulin-like Growth Factors (42 papers), Congenital Diaphragmatic Hernia Studies (11 papers) and Thyroid Disorders and Treatments (9 papers). B. Klinger is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (42 papers), Congenital Diaphragmatic Hernia Studies (11 papers) and Thyroid Disorders and Treatments (9 papers). B. Klinger collaborates with scholars based in Israel, Australia and Denmark. B. Klinger's co-authors include Zvi Laron, A. Silbergeld, P. Lilos, Yaron Avitzur, R. Eshet, Zvi Laron, Avraham Karasik, Hannah Kanety, L. T. Jensen and D. E. L. Wilcken and has published in prestigious journals such as The Lancet, Metabolism and Archives of Disease in Childhood.

In The Last Decade

B. Klinger

43 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Klinger Israel 23 1.3k 521 467 237 237 43 1.5k
C Hauri Switzerland 12 1.1k 0.8× 607 1.2× 255 0.5× 173 0.7× 181 0.8× 12 1.3k
C Lassarre France 22 1.6k 1.2× 786 1.5× 360 0.8× 210 0.9× 219 0.9× 33 2.0k
Klaus Amburn United States 10 1.0k 0.8× 325 0.6× 255 0.5× 156 0.7× 125 0.5× 11 1.1k
Jürgen Klammt Germany 18 872 0.7× 526 1.0× 569 1.2× 222 0.9× 88 0.4× 62 1.6k
Michael P. Wajnrajch United States 19 978 0.7× 444 0.9× 409 0.9× 167 0.7× 121 0.5× 63 1.4k
Guilhèrme Pòvoa Sweden 13 998 0.8× 537 1.0× 193 0.4× 191 0.8× 169 0.7× 17 1.2k
M C Slootweg Netherlands 14 833 0.6× 481 0.9× 289 0.6× 94 0.4× 79 0.3× 16 1.2k
G. Plewe Germany 14 1.1k 0.9× 350 0.7× 288 0.6× 329 1.4× 82 0.3× 19 1.6k
J.M.P. Holly United Kingdom 21 785 0.6× 395 0.8× 201 0.4× 93 0.4× 116 0.5× 33 1.2k
Craig C. Orlowski United States 14 885 0.7× 497 1.0× 245 0.5× 182 0.8× 170 0.7× 19 1.1k

Countries citing papers authored by B. Klinger

Since Specialization
Citations

This map shows the geographic impact of B. Klinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Klinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Klinger more than expected).

Fields of papers citing papers by B. Klinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Klinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Klinger. The network helps show where B. Klinger may publish in the future.

Co-authorship network of co-authors of B. Klinger

This figure shows the co-authorship network connecting the top 25 collaborators of B. Klinger. A scholar is included among the top collaborators of B. Klinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Klinger. B. Klinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laron, Zvi, B. Klinger, & A. Silbergeld. (1999). Serum Insulin-like Growth Factor-I (IGF-I) Levels During Long-term IGF-I Treatment of Children and Adults with Primary GH Resistance (Laron Syndrome). Journal of Pediatric Endocrinology and Metabolism. 12(2). 145–52. 8 indexed citations
2.
Laron, Zvi, et al.. (1997). Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a). European Journal of Endocrinology. 136(4). 377–381. 38 indexed citations
3.
Kanety, Hannah, A. Silbergeld, B. Klinger, et al.. (1997). Long-term effects of insulin-like growth factor (IGF)-I on serum IGF-I, IGF-binding protein-3 and acid labile subunit in Laron syndrome patients with normal growth hormone binding protein. European Journal of Endocrinology. 137(6). 626–630. 14 indexed citations
4.
Silbergeld, A., Florence Dastot, B. Klinger, et al.. (1997). Intronic Mutation in the Growth Hormone (GH) Receptor Gene from a Girl with Laron Syndrome and Extremely High Serum GH Binding Protein: Extended Phenotypic Study in a Very Large Pedigree. Journal of Pediatric Endocrinology and Metabolism. 10(3). 265–74. 40 indexed citations
5.
Laron, Zvi, et al.. (1997). Growth During and 2 Years After Stopping GH Treatment in Prepubertal Children with Idiopathic Short Stature. Journal of Pediatric Endocrinology and Metabolism. 10(2). 191–6. 6 indexed citations
6.
Laron, Zvi, et al.. (1996). Insulin-like growth factor-I decreases serum lipoprotein(a) during long-term treatment of patients with Laron syndrome. Metabolism. 45(10). 1263–1266. 23 indexed citations
7.
Laron, Zvi, Yaron Avitzur, & B. Klinger. (1995). Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment. Metabolism. 44(10 Suppl 4). 113–118. 64 indexed citations
8.
Klinger, B. & Zvi Laron. (1995). Three Year IGF-I Treatment of Children with Laron Syndrome. Journal of Pediatric Endocrinology and Metabolism. 8(3). 149–58. 93 indexed citations
9.
Laron, Zvi, et al.. (1995). Intranasal administration of the GHRP hexarelin accelerates growth in short children. Clinical Endocrinology. 43(5). 631–635. 60 indexed citations
10.
Laron, Zvi & B. Klinger. (1994). IGF‐I treatment of adult patients with Laron syndrome: preliminary results. Clinical Endocrinology. 41(5). 631–638. 56 indexed citations
11.
Eshet, R., Haim Werner, B. Klinger, et al.. (1993). Up-regulation of insulin-like growth factor-I (IGF-I) receptor gene expression in patients with reduced serum IGF-I levels. Journal of Molecular Endocrinology. 10(2). 115–120. 39 indexed citations
12.
Eshet, R., B. Klinger, A. Silbergeld, & Zvi Laron. (1993). Modulation of IGF‐I receptors by exogenous hGH treatment in constitutionally short children. Clinical Endocrinology. 39(6). 687–693. 3 indexed citations
13.
Eshet, R., B. Klinger, A. Silbergeld, & Zvi Laron. (1993). Modulation of insulin like growth factor I (IGF-I) binding sites on erythrocytes by IGF-I treatment in patients with Laron syndrome (LS). Regulatory Peptides. 48(1-2). 233–239. 6 indexed citations
14.
Laron, Zvi, Anne‐Maria Suikkari, B. Klinger, et al.. (1992). Growth hormone and insulin-like growth factor regulate insulin-like growth factor-binding protein-1 in Laron type dwarfism, growth hormone deficiency and constitutional short stature. European Journal of Endocrinology. 127(4). 351–358. 19 indexed citations
15.
Silbergeld, A., et al.. (1992). Serum Prolactin in Patients with Laron-Type Dwarf ism: Effect of Insulin-Like Growth Factor I. Hormone Research. 37(4-5). 160–164. 16 indexed citations
16.
Laron, Zvi, et al.. (1992). Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism. The Lancet. 339(8804). 1258–1261. 146 indexed citations
17.
Laron, Zvi, et al.. (1991). Biochemical and hormonal changes induced by one week of administration of rIGF‐I to patients with Laron type dwarfism. Clinical Endocrinology. 35(2). 145–150. 58 indexed citations
18.
Klinger, B., Moshe Garty, & Zvi Laron. (1990). Elimination Characteristics of Intravenously AdministeredrIGF-I in Laron-Type Dwarfs. Developmental Pharmacology and Therapeutics. 15(3-4). 196–199. 19 indexed citations
19.
Laron, Zvi, et al.. (1989). Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism. European Journal of Endocrinology. 121(4). 603–608. 48 indexed citations
20.
Laron, Zvi, et al.. (1988). EFFECT OF ACUTE ADMINISTRATION OF INSULIN-LIKE GROWTH FACTOR I IN PATIENTS WITH LARON-TYPE DWARFISM. The Lancet. 332(8621). 1170–1172. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Hauri Breakdown of academic impact, for papers by C Lassarre Breakdown of academic impact, for papers by Klaus Amburn Breakdown of academic impact, for papers by Jürgen Klammt Breakdown of academic impact, for papers by Michael P. Wajnrajch Breakdown of academic impact, for papers by Guilhèrme Pòvoa Breakdown of academic impact, for papers by M C Slootweg Breakdown of academic impact, for papers by G. Plewe Breakdown of academic impact, for papers by J.M.P. Holly Breakdown of academic impact, for papers by Craig C. Orlowski
Rankless by CCL
2026